48,833
edits
Difference between revisions of "Classification of urothelial carcinoma by immunohistochemistry"
Jump to navigation
Jump to search
Classification of urothelial carcinoma by immunohistochemistry (view source)
Revision as of 17:52, 8 March 2024
, 8 Marchno edit summary
(→Sign out: sm tweak) |
|||
| Line 27: | Line 27: | ||
Important note: | Important note: | ||
*Twenty percent of the tumour cells is considered the '''cut-off''' for ''positive'' versus ''negative''.<ref name=pmid34103388/> | *Twenty percent of the tumour cells is considered the '''cut-off''' for ''positive'' versus ''negative''.<ref name=pmid34103388/> | ||
Additional notes: | |||
*CK5 is considered the ''basal'' marker. | |||
*GATA3 is considered the ''luminal'' marker. | |||
**[[CK20]] is considered an alternate luminal marker.<ref name=pmid28632777 >{{cite journal |authors=Sikic D, Keck B, Wach S, Taubert H, Wullich B, Goebell PJ, Kahlmeyer A, Olbert P, Isfort P, Nimphius W, Hartmann A, Giedl J |title=Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis |journal=PLoS One |volume=12 |issue=6 |pages=e0179602 |date=2017 |pmid=28632777 |pmc=5478149 |doi=10.1371/journal.pone.0179602 |url=}}</ref> | |||
==Sign out== | ==Sign out== | ||